In 1992, Baxter (Baxalta) publicized the first recombinant factor VIII(rFVIII). Because it has the same effects as natural coagulation factors without risks of blood-borne virus contamination, it is very popular in the market. The developed countries master mature technologies of recombinant coagulation factors. For example, recombinant coagulation factor VIII now has experienced four rounds of upgradation. The main manufacturers are Bayer, Baxalta, Pfizer, etc. By the end of 2020, no domestic recombinant coagulation factor VIII has been launched in China.
According to this market research, Recombinant Factor VIII developed rapidly after entering China. Its annual sales increased from less than CNY 6 million in 2009 to CNY481 million in 2019, and the CAGR reached 55% in 2009 to 2019. Currently, Recombinant Factor VIII sold on the Chinese market is all imported from Bayer, Baxalta and Pfizer. According to the sales value, Bayer accounted for nearly 70% of the Chinese market in 2019.
The analyst forecasts that with the development of China's economy, patients with hemophilia are more able to pay medical expenses. It is expected that the market scale of Recombinant Factor VIII in China will continue to increase from 2020 to 2024. After 2022, there is a possibility that Chinese companies may launch Recombinant Factor VIII.
Topics Covered:
- Development of Recombinant Factor VIII in China
- Sales volume and value of Recombinant Factor VIII in China
- Sales volume and value of Recombinant Factor VIII in regions of China
- Price of Recombinant Factor VIII in the Chinese market
- Key players of Recombinant Factor VIII in the Chinese market
- Research progress of Chinese companies on Recombinant Factor VIII
- Chinese market prospects on Recombinant Factor VIII from 2020 to 2024
Table of Contents
Companies Mentioned
- Baxalta
- Bayer
- Pfizer
- Wyeth
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
